Expression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina

Experimental Eye Research

Volumn 89, Issue 4, 2009, Pages 532-537

  Wright, William S ^a   McElhatten, Robert M ^a   Harris, Norman R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

diabetes; immunofluorescence; mouse; Rat; streptozotocin; thromboxane synthase; thromboxane prostanoid receptor

Indexed keywords

BUFFER; PROSTANOID RECEPTOR; STREPTOZOCIN; THROMBOXANE RECEPTOR; THROMBOXANE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ENUCLEATION; EXPERIMENTAL MODEL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; STREPTOZOCIN DIABETES; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, WISTAR; RECEPTORS, THROMBOXANE; RETINA; THROMBOXANE-A SYNTHASE;

EID: 69849112742     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.05.008     Document Type: Article

References (21)

1. Birkle D.L., and Bazan N.G. Effect of K+ depolarization on the synthesis of prostaglandins and hydroxyeicosatetra(5,8,11,14)enoic acids (HETE) in the rat retina. Evidence for esterification of 12-HETE in lipids. Biochim. Biophys. Acta 795 (1984) 564-573
2. Cai J., and Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 16 (2002) 242-260
3. Chen J., and Nathans J. Genetic ablation of cone photoreceptors eliminates retinal folds in the retinal degeneration 7 (rd7) mouse. Invest Ophthalmol. Vis. Sci. 48 (2007) 2799-2805
4. Chen Z., Prasad S., and Cynader M. Localisation of thromboxane A2 receptors and the corresponding mRNAs in human eye tissue. Br. J. Ophthalmol. 78 (1994) 921-926
5. De La Cruz J.P., Moreno A., Ruiz-Ruiz M.I., Garcia C.J., and Sanchez d.l.C. Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. Eur. J. Pharmacol. 350 (1998) 81-85
6. De La Cruz J.P., Moreno A., Ruiz-Ruiz M.I., and Sanchez d.l.C. Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. Thromb. Res. 97 (2000) 125-131
7. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris III F.L., and Klein R. Retinopathy in diabetes. Diabetes Care 27 Suppl 1 (2004) S84-S87
8. Giulian D., Corpuz M., Richmond B., Wendt E., and Hall E.R. Activated microglia are the principal glial source of thromboxane in the central nervous system. Neurochem. Int. 29 (1996) 65-76
9. Hardy P., Beauchamp M., Sennlaub Jr. F., G.F., Mwaikambo B., Lachapelle P., and Chemtob S. Inflammatory lipid mediators in ischemic retinopathy. Pharmacol. Rep. 57 Suppl. (2005) 169-190
10. Honma S., Saika M., Ohkubo S., Kurose H., and Nakahata N. Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. Eur. J. Pharmacol. 545 (2006) 100-108
11. King G.L., Kunisaki M., Nishio Y., Inoguchi T., Shiba T., and Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 45 Suppl 3 (1996) S105-S108
12. Kulkarni P.S. Arachidonic acid metabolism in human and bovine retina. J. Ocul. Pharmacol. 7 (1991) 135-139
13. Lee S., and Harris N.R. Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice. Microcirculation 15 (2008) 379-387
14. Lee S., Morgan G.A., and Harris N.R. Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina. Microvasc. Res. 76 (2008) 217-223
15. Moreno A., De La Cruz J.P., Garcia C.J., and Sanchez d.l.C. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. Can. J. Ophthalmol. 30 (1995) 117-123
16. Nishiguchi K.M., Kaneko H., Nakamura M., Kachi S., and Terasaki H. Identification of photoreceptor precursors in the pars plana during ocular development and after retinal injury. Invest. Ophthalmol. Vis. Sci. 49 (2008) 422-428
17. Preud'homme Y., Demolle D., and Boeynaems J.M. Metabolism of arachidonic acid in rabbit iris and retina. Invest Ophthalmol. Vis. Sci. 26 (1985) 1336-1342
18. Setty B.N., Phelps D.L., Walenga R.W., and Stuart M.J. Identification of prostaglandins and hydroxyeicosatetraenoic acids in kitten retina: comparison with other species. Exp. Eye Res. 53 (1991) 81-88
19. Ullrich V., Zou M.H., and Bachschmid M. New physiological and pathophysiological aspects on the thromboxane A(2)-prostacyclin regulatory system. Biochim. Biophys. Acta 1532 (2001) 1-14
20. Wright W.S., and Harris N.R. Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina. Exp. Eye Res. 86 (2008) 528-536
21. Wright W.S., Messina J.E., and Harris N.R. Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist. Exp. Eye Res. 88 (2009) 106-112